CD4 and COVID-19: The analysis found that whilst the frequencies of CD4 + T cells were reduced on Day 211 compared to Day 36, for some participants they remained higher compared to baseline, placebo-controlled, and COVID-19 pre-pandemic samples (Figure 5a).